1004 NEW ZEALAND GAZETTE, No. 33 15 MARCH 2012

I hereby cancel the licence dated 12 September 2011, which was granted under those Regulations to Arlene Troy in respect of Topkids Motutaiko Infants Centre (45536), situated at 9 Motutaiko Street, Kinloch, Taupo.

This notice shall take effect the day after the date of its notification in the New Zealand Gazette.

MARLENE CLARKSON, Acting Senior Manager, Implementation Planning, Early Childhood Education.

go1540

Cancellation of Licence for an Early Childhood Service

Pursuant to Regulation 32(1)(d)(i) of the Education (Early Childhood Services) Regulations 2008, and acting under authority delegated by the Secretary for Education, I hereby cancel the licence dated 23 January 2012, which was granted under those Regulations to Nicola Thomas in respect of Topkids Mount 02 (30074), situated at 39 Macdonald Street, Mt Maunganui.

This notice shall take effect the day after the date of its notification in the New Zealand Gazette.

MARLENE CLARKSON, Acting Senior Manager, Implementation Planning, Early Childhood Education.

go1541

Cancellation of Licence for an Early Childhood Service

Pursuant to Regulation 32(1)(d)(i) of the Education (Early Childhood Services) Regulations 2008, and acting under authority delegated by the Secretary for Education, I hereby cancel the licence dated 23 January 2012, which was granted under those Regulations to Nicola Thomas in respect of Topkids Mt 03 (30029), situated at 39 Macdonald Street, Mount Maunganui.

This notice shall take effect the day after the date of its notification in the New Zealand Gazette.

MARLENE CLARKSON, Acting Senior Manager, Implementation Planning, Early Childhood Education.

go1542

Health

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
ARTISS

Active Ingredients:
Aprotinin 2250kIU/mL – 3750kIU/mL
Fibrinogen 72mg/mL – 100mg/mL

Dosage Form:
Syringe 1 Topical solution

Active Ingredients:
Calcium chloride dihydrate 0.036mmol/mL – 0.044mmol/mL
Thrombin 2.5IU/mL – 6.5IU/mL

Dosage Form:
Syringe 2 Topical solution

New Zealand Sponsor:
Baxter Healthcare Limited

Manufacturer:
Baxter AG, Vienna, Austria

Product:
Oxybutynin ADE 2.5

Active Ingredient:
Oxybutynin hydrochloride 2.5mg

Dosage Form:
Tablet

New Zealand Sponsor:
Boucher & Muir (New Zealand) Limited t/a BNM Group

Manufacturer:
Farmaceutisch Analytisch Laboratorium Duiven B.V., Duiven, The Netherlands

Product:
Oxybutynin ADE 5

Active Ingredient:
Oxybutynin hydrochloride 5mg

Dosage Form:
Tablet

New Zealand Sponsor:
Boucher & Muir (New Zealand) Limited t/a BNM Group

Manufacturer:
Farmaceutisch Analytisch Laboratorium Duiven B.V., Duiven, The Netherlands

Product:
Pantoprazole

Active Ingredient:
Pantoprazole sodium sesquihydrate 22.55mg equivalent to pantoprazole base 20mg

Dosage Form:
Modified release tablet

New Zealand Sponsor:
Dr Reddy’s New Zealand Limited

Manufacturer:
Dr Reddy’s Laboratories Limited, Andhra Pradesh, India

Dated this 8th day of March 2012.

DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go1474